Orient Pharma Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 353.539 million compared to TWD 269.539 million a year ago. Operating loss was TWD 205.367 million compared to TWD 249.056 million a year ago. Net loss was TWD 201.027 million compared to TWD 160.101 million a year ago. Basic loss per share was TWD 1.29 compared to TWD 1.03 a year ago.